According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032.
Checkpoint inhibitor refractory cancer occurs when tumors develop...
The Oncology Small Molecule Drugs Market is evolving rapidly as pharmaceutical innovators and healthcare systems worldwide intensify efforts against cancer with advanced therapeutics and strategic investments. According to the latest Oncology Small Molecule Drugs Market report by The Insight Partners, this market is poised to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek